CARD9 and atherosclerosis: Metformin treatment abolished the acceleration of atherosclerosis observed in Card9 deficiency, with no difference in plaque size (Fig. 5E), plaque composition (Fig. 5F, G) and P62 accumulation (Fig. 5H) between the 2 treated groups.